2-Methoxy-5-(3,4,5-trimethoxy-phenoxymethyl)-phenol

ID: ALA345556

PubChem CID: 10336128

Max Phase: Preclinical

Molecular Formula: C17H20O6

Molecular Weight: 320.34

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(COc2cc(OC)c(OC)c(OC)c2)cc1O

Standard InChI:  InChI=1S/C17H20O6/c1-19-14-6-5-11(7-13(14)18)10-23-12-8-15(20-2)17(22-4)16(9-12)21-3/h5-9,18H,10H2,1-4H3

Standard InChI Key:  JXIPAFNBJWGSFY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 23 24  0  0  0  0  0  0  0  0999 V2000
   -2.4250   -0.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1458   -0.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1125    0.2625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5125    0.2458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5458   -0.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1667   -0.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2250   -0.2875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4542   -0.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5667   -0.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6250   -0.3042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1375   -1.4000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2542   -0.8500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0333   -0.2167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4625   -1.2792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3958    0.7958    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4792    0.1583    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3458   -0.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5375   -1.3792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0542   -0.9042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3125    0.3083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9958    0.8208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1833   -1.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3292   -1.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  1  1  0
  4  3  2  0
  5  2  1  0
  6  9  2  0
  7  4  1  0
  8 11  2  0
  9 12  1  0
 10  7  1  0
 11 18  1  0
 12 17  1  0
 13  1  1  0
 14  2  1  0
 15  3  1  0
 16  6  1  0
 17 10  1  0
 18 12  2  0
 19  8  1  0
 20 13  1  0
 21 15  1  0
 22 14  1  0
 23 19  1  0
  7  5  2  0
  8  6  1  0
M  END

Alternative Forms

Associated Targets(Human)

K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TUBB1 Tclin Tubulin beta-1 chain (182 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TUBB4B Tclin Tubulin (5180 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Tubulin (1327 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 320.34Molecular Weight (Monoisotopic): 320.1260AlogP: 3.01#Rotatable Bonds: 7
Polar Surface Area: 66.38Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 9.81CX Basic pKa: CX LogP: 2.61CX LogD: 2.60
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.85Np Likeness Score: 0.21

References

1. Lawrence NJ, Rennison D, Woo M, McGown AT, Hadfield JA..  (2001)  Antimitotic and cell growth inhibitory properties of combretastatin A-4-like ethers.,  11  (1): [PMID:11140732] [10.1016/s0960-894x(00)00596-5]
2. Ducki S, Mackenzie G, Lawrence NJ, Snyder JP..  (2005)  Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly.,  48  (2): [PMID:15658859] [10.1021/jm049444m]
3. Uddin R, Naz A, Akhtar N, Zaheer ul Haq.  (2013)  Development of robust QSAR model using rapid overlay of crystal structures (ROCS) based alignment: a test case of Tubulin inhibitors,  22  (7): [10.1007/s00044-012-0327-0]

Source